Discovering & applying novel formulation technologies and drug delivery platforms to enhance existing & emerging pharmaceutical therapies’

Be part of the Drug Delivery & Formulation Summit Asia

The pharmaceutical industry is experiencing significant growth in emerging markets, which are estimated to constitute more than half of global market growth in 2012 alone. Of these, China is expected to rank 3rd with surrounding nations, including India, Japan and South Korea, also in the top 10.

Government investment, growth in consumer wealth and expansion of medical infrastructure are only a few examples of the key drivers promoting the Asian pharmaceutical development market. The Drug Delivery & Formulation Summit Asia sources and presents leading global case studies from Pfizer, GSK, Novartis, Merck, Eli Lilly and many more. The summit is packed full of real life case studies, allowing you to benchmark your business approach & technologies against ‘best in class’ and ensure that you have the tools you need to form a coherent and logical strategy.

Take a look at the full program.